Literature DB >> 6975673

Human spleen as a source of T cell growth factor.

A Moretta, M Colombatti, B Chapuis.   

Abstract

Human spleen cells were tested for the ability to produce T cell growth factor (TCGF) upon stimulation with PHA. Quantitative analysis of the amounts of TCGF produced under optimal conditions indicated that supernatants obtained from spleen cell cultures were approximately five times more active than those derived from peripheral blood leucocytes (PBL). Moreover, in contrast to PBL, there was no significant difference in TCGF production between individual spleen cell populations. Among splenic T cells, TG-depleted cell fractions were superior to TG-enriched cell fractions in producing TCGF upon PHA stimulation. These supernatants induced intense proliferation of blast cell populations isolated from mixed leucocyte-tumour cell cultures (MLTC) established with PBL and irradiated allogeneic myelogenous leukaemic cells. Within 7 days of culture in TCGF, the number of MLTC blast cells increased approximately 300-fold. Concomitantly, the lytic activity (on a per-cell basis) of these populations against the corresponding myelogenous leukaemic cell targets increased approximately 80-fold.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975673      PMCID: PMC1537347     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Human T cell growth factor. I. Optimal conditions for its production.

Authors:  J M Alvarez; A Silva; M O de Landazuri
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Functional and morphologic characterization of human T cells continuously grown in vitro.

Authors:  F W Ruscetti; D A Morgan; R C Gallo
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

3.  Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC.

Authors:  J E Ryser; J C Cerottini; K T Brunner
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

5.  Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements.

Authors:  B Chapuis; B M Summersgill; P Cocks; P Howard; S D Lawler; P Alexander; R Powles
Journal:  Cryobiology       Date:  1977-12       Impact factor: 2.487

Review 6.  Quantitation and cloning of cytolytic T lymphocytes and their precursors.

Authors:  H R MacDonald; J C Cerottini; J E Ryser; J L Maryanski; C Taswell; M B Widmer; K T Brunner
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

7.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

8.  Mechanism of target cell lysis of cytolytic T lymphocytes. I. Characterization of specific lymphocyte-target cell conjugates separated by velocity sedimentation.

Authors:  J E Ryser; B Sordat; J C Cerottini; K T Brunner
Journal:  Eur J Immunol       Date:  1977-02       Impact factor: 5.532

9.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  12 in total

Review 1.  [Role of the spleen in tumor surgery].

Authors:  U Wolters; H W Keller; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1991

2.  Phosphorylation of human interleukin-2 (IL-2).

Authors:  H F Kung; I Calvert; E Bekesi; F R Khan; K P Huang; S Oroszlan; L E Henderson; T D Copeland; R C Sowder; S J Wei
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

3.  Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma.

Authors:  T Akiyoshi; F Koba; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1988-03

4.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

5.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Functional and phenotypical studies of the Leu-4 (CD3)+, Leu-1 (CD5)- T lymphocyte.

Authors:  E F Srour; E B Walker; D E Walker; J Jansen
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

7.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

8.  Molecular cloning of human interleukin 2 cDNA and its expression in E. coli.

Authors:  R Devos; G Plaetinck; H Cheroutre; G Simons; W Degrave; J Tavernier; E Remaut; W Fiers
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

9.  Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.

Authors:  A Moretta; G Pantaleo; M C Mingari; L Moretta; J C Cerottini
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations.

Authors:  A Moretta; G Pantaleo; L Moretta; M C Mingari; J C Cerottini
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.